Institution
Puigvert Foundation
Also known as: Fundació Puigvert · Fundación Puigvert
- 28running trials
- 11closed trials
- 3,755publications (OpenAlex)
Running trials
Active, not recruiting
A study to learn about how well BAY 3401016 works in adults with Alport syndrome
Recruiting
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Recruiting
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
Recruiting
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Recruiting
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Active, not recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer7 recruiting
- IgA nephropathy2 recruiting
- Polycystic kidney disease2 recruiting
- Prostate cancer2 recruiting
- ANCA-associated vasculitis1 recruiting
- Chronic kidney disease1 recruiting
- Kidney cancer1 recruiting
Closed trials
Active, not recruiting
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
Active, not recruiting
Completed
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Registry name variants (8)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Fundació Puigvert
Barcelona, 08025
35 trials
Fundaciòn Puigvert
Barcelona
1 trial
NCT03994471Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Contact: Maria Alba Herreros, MD
FUNDACION PUIGVERT - Nephrology Department
Barcelona, 08025
1 trial
Fundacio Puigvert
Badalona, 8025
1 trial
Puigvert Foundation
Barcelona, Catalonia 08025
1 trial
NCT06774131A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Contact: Vanesa Munoz
Fundacio Puigvert
Viladecans, Barcelona 8840
Fundacio Puigvert (Site 0864)
Barcelona, 08025
Barcelona
Barcelona, 8025
Conditions
Diseases this institution publishes on or runs trials for.
- Bladder cancer38 works · 18 trials
- Testicular cancer3 works · 0 trials
Institution data: ROR 03qwx2883 (CC0-1.0)Updated 15 Nov 2026